<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02113423</url>
  </required_header>
  <id_info>
    <org_study_id>FJCH009911</org_study_id>
    <nct_id>NCT02113423</nct_id>
  </id_info>
  <brief_title>Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma</brief_title>
  <official_title>Superiority of Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujian Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujian Cancer Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the study is to address the efficacy and toxicity profile of aforementioned
      four modalities for rT1-2 NPC.

      Characters of the patients:

        -  list item one: 168 patients, median age 48 years (range 16-75 years） proven rT1-2 NPC
           were diagnosed

        -  list item two: Treated with four different irradiation modalities(3D-CRT,IMRT, BT , BT
           Combined 3D-CRT or IMRT).

        -  list item three: Median time to recurrence was 30 months (range 1-180months). The median
           follow-up time was 28 months (range, 4-135 months).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      Recurrent T1-2 Nasopharyngeal Carcinoma (rT1-2) may be salvaged by 3D - CRT（3D-Conformal
      Radiotherapy）, IMRT（ Intensity Modulated Radiotherapy）, Brachytherapy (BT), BT combined 3D -
      CRT or IMRT . The aim of this study is to address the efficacy and toxicity profile of
      aforementioned four modalities for rT1-2 NPC.

      Methods and Materials:

      168 patients, median age 48 years (range 16-75 years） proven rT1-2 NPC were diagnosed and
      treated with four different irradiation modalities(3D-CRT,IMRT, BT , BT Combined 3D-CRT or
      IMRT) . Median time to recurrence was 30 months (range 1-180months). The median follow-up
      time was 28 months (range, 4-135 months).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1996</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>thirteen years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Nasopharyngeal Cancer Recurrent</condition>
  <arm_group>
    <arm_group_label>recurrent T1-2 NPC,no treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT</intervention_name>
    <description>3D - CRT（3D-Conformal Radiotherapy）: CTV-P 50-60Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week) IMRT（Intensity Modulated Radiotherapy）: GTV-P 50-60 Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week) BT(Brachytherapy): 2.5Gy BID*10F one week interval BT combined 3D - CRT or IMRT: First,GTV-P 40Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week);Then, 2.5Gy BID*2F</description>
    <arm_group_label>recurrent T1-2 NPC,no treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  recurrent T1-2 nasopharyngeal carcinoma patients

        Exclusion Criteria:

          -  non recurrent T1-2 nasopharyngeal carcinoma patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianji Pan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Radiation Oncology, Cancer Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fujian Cancer Hospital Radiation Oncology Department</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2014</study_first_submitted>
  <study_first_submitted_qc>April 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2014</study_first_posted>
  <last_update_submitted>April 10, 2014</last_update_submitted>
  <last_update_submitted_qc>April 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>superiority, re-irradiation, IMRT, recurrent T1-2 NPC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

